New concepts in the pathogenesis and modalities of the chemoprophylaxis of native valve endocarditis.
Recommendations for the prophylaxis of BE have changed over the last 10-15 years toward fewer-dose and oral regimens. An advisory committee of the AHA is currently formulating new guidelines for the prevention of BE that will likely be promulgated in 1990 or 1991. It is anticipated that such recommendations will feature the new information on MVP and focus on oral prophylactic regimens.
Bayer
A S
AS
Department of Medicine, Harbor-UCLA Medical Center, Torrance.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004697:Endocarditis, Bacterial / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D011292:Premedication; D012307:Risk Factors; D018805:Sepsis / Q000517:prevention & control
D000900:Anti-Bacterial Agents